clarke-dur by peirongw



September 2006-June 2007

Recent declines in breast cancer: Why and will they last?
Tina Clarke, PhD
Dr. Clarke is a Research Scientist II and Northern California Cancer Center Lecturer at the Department of Health Research and Policy at Stanford University in Fremont, CA.

Learning Objective:
To describe recent changes in breast cancer incidence patterns in California and beyond; to discuss the possible reasons for these changes and their relevance to ongoing breast cancer control efforts.

Target Audience
Researchers and clinicians actively involved in topics that relate to cancer prevention and control

Tuesday, June 5, 2007, 11:00 am Executive Plaza North Conference Room G 6130 Executive Boulevard Rockville, Maryland

For Additional Information
Office of Preventive Oncology (301) 496-8640
If you are a person with a disability and require any assistive device, services or other reasonable accommodation to participate in this activity, please contact the Office of Preventive Oncology at 301-496-8640 at least one week in advance of the lecture date to discuss your accommodation needs.

Educational objectives: To better comprehend current research in various aspects of cancer prevention and control, including current challenges and methods used by investigators to address gaps, advance he field, and promote application of successful strategies, and to better identify various biostatistical methods and appropriate conditions fro application in cancer prevention and control research. The National Institutes of Health/Foundation for Advanced Education in the Sciences (NIH/FAES) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The NIH/FAES designates this educational activity for a maximum of 37 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Department of Health and Human Services, National Institutes of Health

To top